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Background
Clinical study of the correlation of plasma Vitamin B12
levels and mood disorders in a patient with history of
long term treatment with antiepileptic drugs. A female
patient with bipolar disorder II, treated in the near past
with carbamazepine and sodium valproate, during her
stay in our clinic ward mentioned weakness and loss of
sensation in both arms, accompanied with a filling of
unstable walking and hemodia. After the full neurologi-
cal clinical evaluation and examination with structural
neuroimaging procedures such a CT scan and MRI, our
attention was moved to the possible relationship
between the reported symptoms with the B12 serum
levels. As the levels were 150 pg/ml and our patient’s
blood cell values do not reveal megaloblastic anaemia,
we started substitute treatment, provided that she had
been taking antiepileptic medicine for years and had low
toxicity of B12. At following neurological examinations
the patient’s clinical icon had improved. Carbamazepine
and sodium valproate are widely used as maintenance
treatment of bipolar disorder. Although the alteration of
accumulation of B12 in serum is not totally acceptable
by scientists, there are indications for the relation
between antiepileptic medicine and reduced levels of
B12 at least at cerebrospinal fluid folate. Additionally,
the combination of any inefficiency with the chronic
alcoholism that is often present in this category of men-
tal patients and the rise of life expectancy creates the
need of a bigger demanded quantity of B12 in their diet.
Materials and methods
Clinical examination, laboratory tests, neuroimaging and
bibliographic research.
Results
The full spectrum of relations between B12 and psychia-
tric illness is still not clear. Much of the evidence comes
from case-control and cross-sectional studies. Cohort
studies and definitive randomized-controlled trials to
test the therapeutic benefit of B12 are required to con-
firm or refute any causal relationship. Evidence suggest-
ing a causal relationship between the disturbed vitamin
metabolism and the abnormal mental state.
Conclusions
The introduction in routine laboratory test of the deter-
mination of B12 serum levels under the evidence of the
association of B12 deficiency and low serum B12 values
in patients with mental disorders and atypical psychia-
tric symptoms may help. As the neuropsychiatric sever-
ity by vitamin B12 deficiency and the therapeutic
efficacy depends on the duration of signs and symptoms,
the B12 levels should be evaluated in every patient with
history of treatment with antiepileptic drugs, resistant
depressive disorders, dementia, psychosis or risk factors
for malnutrition such as alcoholism or advancing age
associated with neurological symptoms, anaemia, malab-
sorption, gastrointestinal surgery, parasite infestation or
strict vegetarian diet.
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